Synonym
Anticonvulsant 7903; Lvguidingan; Chlocibutamine.
IUPAC/Chemical Name
(E)-N-butan-2-yl-3-(3,4-dichlorophenyl)prop-2-enamide
InChi Key
WMHSFCNWWYFBSS-FNORWQNLSA-N
InChi Code
InChI=1S/C13H15Cl2NO/c1-3-9(2)16-13(17)7-5-10-4-6-11(14)12(15)8-10/h4-9H,3H2,1-2H3,(H,16,17)/b7-5+
SMILES Code
O=C(NC(CC)C)/C=C/C1=CC=C(Cl)C(Cl)=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Biological target:
Lvguidingan, also known as Anticonvulsant 7903, is an Anticonvulsant agent.
|
Solvent |
mg/mL |
mM |
| Solubility |
| Ethanol |
54.0 |
198.41 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
272.17
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
Formulation protocol:
TBD
1: Patejdl R, Leroux AC, Noack T. Phenytoin inhibits contractions of rat gastrointestinal and portal vein smooth muscle by inhibiting calcium entry. Neurogastroenterol Motil. 2015 Oct;27(10):1453-65. doi: 10.1111/nmo.12645. PubMed PMID: 26265316.
2: Yamada K, Toribe Y, Kimizu T, Kimura S, Ikeda T, Mogami Y, Yanagihara K, Mano T, Suzuki Y. Predictive value of EEG findings at control of epileptic spasms for seizure relapse in patients with West syndrome. Seizure. 2014 Oct;23(9):703-7. doi: 10.1016/j.seizure.2014.05.010. PubMed PMID: 24939523.
3: Karimzadeh P, Sedighi M, Beheshti M, Azargashb E, Ghofrani M, Abdollahe-Gorgi F. Low Glycemic Index Treatment in pediatric refractory epilepsy: the first Middle East report. Seizure. 2014 Aug;23(7):570-2. doi: 10.1016/j.seizure.2014.03.012. PubMed PMID: 24795151.
4: Uhl RL, Roberts TT, Papaliodis DN, Mulligan MT, Dubin AH. Management of chronic musculoskeletal pain. J Am Acad Orthop Surg. 2014 Feb;22(2):101-10. doi: 10.5435/JAAOS-22-02-101. Review. PubMed PMID: 24486756.
5: Yong W, Zhang MM, Wang S, Ruan DY. Effects of sodium valproate on synaptic transmission and neuronal excitability in rat hippocampus. Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1062-7. doi: 10.1111/j.1440-1681.2009.05186.x. PubMed PMID: 19413604.
6: Pençe S, Erkutlu I, Kurtul N, Alptekin M, Tan U. Effects of progesterone on total brain tissue adenosine deaminase activity in experimental epilepsy. Int J Neurosci. 2009;119(2):204-13. doi: 10.1080/00207450802055374. PubMed PMID: 19125374.
7: Isler CM, Barrilleaux PS, Rinehart BK, Magann EF, Martin JN Jr. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. Obstet Gynecol. 2003 Jan;101(1):66-9. PubMed PMID: 12517647.
8: Cao LG, Pei YQ. [Analysis of the mechanism of anticonvulsant action of 3, 4-dichlorophenyl propenyl isobutylamide (7903)]. Yao Xue Xue Bao. 1982 Dec;17(12):889-93. Chinese. PubMed PMID: 7183120.
